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SUMMARY. A simple reversed phase HPLC method was developed for simultaneous estimation of piogli-
tazone, glibenclamide, and glibenclamide impurities A and B from a combination drug product. The drugs
and impurities are well separated using a reverse phase liquid chromatography with C-8 column. The iso-
cratic mobile phase comprising phosphate buffer (pH 5.0): acetonitrile in the ratio of 75:25 (v/v) at 1.0
mL/min flow rate, UV detection at 250 nm, column temperature was maintained at 30 °C and the injection
volume was used 150 μL. The proposed method was validated according to the ICH guidelines and proved
suitable for routine analysis and quality control testing of these drugs in pharmaceutical preparations.
